Zimmer Biomet Holdings (ZBH) Common Equity (2009 - 2026)

Zimmer Biomet Holdings' Common Equity history runs 18 years deep, the most recent figure standing at $12.7 billion for Q1 2026.

• In Q1 2026, Common Equity rose 2.17% year-over-year to $12.7 billion; the TTM figure through Mar 2026 stood at $12.7 billion (up 2.17% YoY), while the FY2025 annual figure was $12.7 billion, up 1.78% from the prior year.
• Common Equity was $12.7 billion for Q1 2026 at Zimmer Biomet Holdings, roughly flat from $12.7 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $12.8 billion in Q3 2025 to a low of $12.0 billion in Q1 2022.
• Historically, Common Equity has averaged $12.4 billion across 5 years, with a median of $12.5 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Common Equity fell 5.05% in 2022, then climbed 3.83% in 2023.
• A 5-year view of Common Equity shows it stood at $12.0 billion in 2022, then climbed by 3.83% to $12.5 billion in 2023, then slipped by 0.1% to $12.5 billion in 2024, then climbed by 1.78% to $12.7 billion in 2025, then declined by 0.19% to $12.7 billion in 2026.
• The last three Common Equity figures came in at $12.7 billion (Q1 2026), $12.7 billion (Q4 2025), and $12.8 billion (Q3 2025), per Business Quant data.